|
FDA Petitioned to Revise Label, Indications for Opioids
A coalition of physicians, clinicians and health officials is asking the FDA to tighten up the language in opioid labels regarding indications and long-term use for non-cancer pain.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives